Community-Acquired Skin Infections in the Age of Methicillin-Resistant Organisms Table 15. Time to resolution according to various characteristics, retrospective, prospective, and all cases Retrospective (N = 263)Prospective (N = 114)Total (N = 377) NTime to Resolution(Days)ANOVAP-ValueNTime to Resolution(Days)Anova P-ValueNTime to Resolution(Days)ANOVA P-ValueDemographicsGender Female Male13113210.8 ± 6.310.8 ± 6.30.028664814.7 ± 8.615.9 ± 11.50.52919718012.1 ± 7.413.7 ± 9.50.079Age group (years) < 20 20 to < 40 40 to < 65 65 to 966066884810.8 ± 4.511.4 ± 6.212.6 ± 10.112.4 ± 7.10.4672734381418.1 ± 14.913.4 ± 8.514.4 ± 7.216.3 ± 6.70.280871001266213.1 ± 9.712.1 ± 7.113.2 ± 9.313.3 ± 7.10.768Age group (years) < 40 ≥4012613611.2 ± 5.512.6 ± 9.10.129615215.5 ± 12.014.9 ± 7.00.73318718812.6 ± 8.413.2 ± 8.60.465Rurality Non-rural Rural1838010.7 ± 6.314.6 ± 9.0< 0.001823114.9 ± 9.316.3 ± 11.40.52026511112.0 ± 7.615.1 ± 10.00.004Insurance Private Medicaid Medicare Uninsured15244441811.7 ± 7.811.3 ± 8.012.8 ± 7.711.6 ± 5.60.824762010214.5 ± 10.714.9 ± 8.220.1 ± 8.215.0 ± 1.40.43322864542012.7 ± 8.912.4 ± 8.214.1 ± 8.212.8 ± 8.50.641Race Caucasian Non-Caucasian191812.5 ± 8.08.5 ± 1.60.163107715.4 ± 10.112.9 ± 6.80.5152981513.5 ± 8.910.5 ± 5.10.198Ethnicity Hispanic Non-Hispanic1017813.4 ± 10.812.6 ± 8.20.77321128.5 ± 7.815.3 ± 9.90.3341229012.6 ± 10.213.7 ± 9.00.682Patient Presenting CharacteristicsSite of Infection Face/neck Groin/pubic/ lower extremities Thorax/upper extremities3412210413.5 ± 10.713.4 ± 8.59.6 ± 4.1<0.00115474518.3 ± 10.715.8 ± 11.513.2 ± 7.30.1844916914915.0 ± 10.814.0 ± 9.410.7 ± 5.5< 0.001Temperature (°F) < 99° ≥99°2062411.5 ± 7.315.1 ± 10.00.0311011014.6 ± 9.220.8 ± 16.00.2563073412.5 ± 8.116.8 ± 12.10.053Duration of infection prior to being seen < 5 days ≥5 days1328911.4 ± 6.713.1 ± 8.90.099654115.0 ± 11.315.4 ± 8.30.85119713012.6 ± 8.613.9 ± 8.80.199Patient hospitalized Yes No1125221.6 ± 14.911.4 ± 6.8<0.001310931.0 ± 26.314.6 ± 8.80.3921436123.6 ± 17.112.4 ± 7.60.029Patient had at least 1 risk factor Yes No6919413.8 ± 8.911.2± 6.90.016397515.6 ± 9.215.0 ± 10.3076510826914.4 ± 9.012.3 ± 8.20.025Patient had diabetes Yes No3522815.4 ± 10.411.3 ± 6.90.032199515.1 ± 4.415.3 ± 10.70.8885432315.3 ± 8.712.5 ± 8.40.026Wound type Abscess only Cellulitis only Abscess and cellulitis931432710.5 ± 6.112.3 ± 8.114.0 ± 8.60.05918662418.4 ± 13.815.1 ± 9.714.0 ± 7.20.3471112095111.8 ± 8.313.2 ± 8.714.0 ± 7.90.224Treatment at OfficeIncision and drainage done Yes No8517810.2 ± 5.612.7 ± 8.30.014328214.4 ± 8.415.5 ± 10.40.58211726011.4 ± 6.713.6 ± 9.10.019Culture done Yes No9217113.4 ± 8.711.1 ± 6.80.029506413.4 ± 7.316.7 ± 11.40.08814223513.4 ± 8.212.6 ± 8.70.368Wound packed Wound packed Wound not packed Incision and drainage not done30551789.8 ± 6.910.5 ± 4.812.7 ± 8.30.0468228219.6 ± 11.212.5 ± 7.015.5 ± 10.40.200387726011.8 ± 8.811.1 ± 5.513.6 ± 9.10.054For those who had incision and Wound packed Wound not packed30559.8 ± 6.910.5 ± 4.80.59282219.6 ± 11.212.5 ± 7.00.046387711.8 ± 8.811.1 ± 5.50.615Antibiotics PrescribedAntibiotic prescribed at first visit Yes No2461712.1 ± 7.79.1 ± 6.00.123111315.3 ± 10.013.7 ± 5.50.7833572013.1 ± 8.69.8 ± 6.00.095Initial antibiotics covered MRSA Yes No7017611.4 ± 6.612.3 ± 8.00.421585615.1 ± 8.715.4 ± 11.10.86212823213.1 ± 7.813.0 ± 8.90.974Antibiotics covered MRSA at some time during infection Yes No9115713.3 ± 8.311.4 ± 7.10.064684616.0 ± 10.014.0 ± 9.70.28615920314.4 ± 9.212.0 ± 7.80.006Total number of antibiotics used over the course of the infection ≤ 2 > 22412210.9 ± 6.422.6 ±10.9< 0.0011031114.1 ± 7.826.1 ± 18.40.0563443311.8 ± 7.023.8 ± 13.6< 0.001Total number of antibiotics used over course of infection 0 1 2 3 4 5 61517650163308.3 ± 5.99.6 ± 3.716.0 ± 10.321.1 ± 10.022.7 ± 12.622.7 ± 12.6< 0.0011772582018.013.9 ± 8.114.9 ± 7.225.3 ± 17.631.0 ± 34.0---23.00.0051625375245318.3 ± 5.711.0 ± 5.815.7 ± 9.322.5 ± 12.826.0 ± 19.730.7 ± 14.623.0< 0.001Return to ContentsFigure 1. Map of offices participating in CA-MRSA studyReturn to ContentsFigure 2. Antibiotics prescribed at initial visitReturn to ContentsFigure 3. Antibiotics prescribed at first follow-up visitReturn to ContentsFigure 4. Antibiotics prescribed at initial prospective visitN=114 individualsReturn to Contents Current as of March 2011 Internet Citation: Community-Acquired Skin Infections in the Age of Methicillin-Resistant Organisms. March 2011. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/findings/final-reports/mrsa/iowa_mrsatabfigs.html